"CSL Plasma was paying an average of $270/month to attract donors, but demand has been so high this year, they've been milking up to $700 per month.
That's more than double the value of product..."
Not sure I follow your argument.
It's more than double the value of the product?
Or double the value of the raw material used to make the product?
If the latter, other things held constant, that's not a good thing, is it?
.
CSL possible pull back to low $200's, page-30
-
- There are more pages in this discussion • 553 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$308.56 |
Change
1.960(0.64%) |
Mkt cap ! $149.1B |
Open | High | Low | Value | Volume |
$308.93 | $311.00 | $306.28 | $198.7M | 643.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 859 | $308.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$308.65 | 5 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 307.700 |
1 | 17 | 307.600 |
1 | 200 | 307.500 |
1 | 71 | 307.470 |
2 | 914 | 307.300 |
Price($) | Vol. | No. |
---|---|---|
308.650 | 5 | 1 |
308.700 | 60 | 1 |
308.720 | 914 | 1 |
308.730 | 71 | 1 |
308.750 | 100 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online